ESR1 and breast neoplasm: DNA methylation status at the ZNF217 locus was lower in estrogen receptor α-positive (ER+) when compared with ER-negative (ER-) breast tumors [36], while ER+ and ER- breast tumors display, respectively, high and low ZNF217 mRNA levels [37].